NCT06236126

Brief Summary

The purpose of this study is to explore the differences between the pain associated with epidural Tuohy needle insertion with prior administration of subcutaneous or intradermal lidocaine using two different pain assessment tools (numerical rate scale (NRS) and Critical-Care Pain Observation Tool (CPOT)) in parturient women requesting epidural analgesia for laboring pain. Subjects will go through the following study procedures: review of medical history prior to surgery. Subjects will be randomly assigned to one of the two study groups in a 1:1 ratio to one of the two different standard methods to administer lidocaine prior to epidural Tuohy needle insertion: intradermal or subcutaneous lidocaine administration. Prior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine either intradermally (Group Intradermal) or subcutaneously (Group Subcutaneous). A blinded observer (positioned in front of the patient and unable to see the procedure) will record baseline NRS scores, HR, and BP after the patient has been positioned for the epidural procedure and prior to the administration of lidocaine. During the procedure, the blinded observer will objectively record patient's vocal responses, facial expressions, bodily movements, and muscle tension (caused by pain reflex) using the CPOT and NRS scales during lidocaine administration and the first Tuohy needle insertion. After each injection, the blinded observer will record the corresponding heart rate. When the procedural anesthesiologist has exited the room, the blinded observer will then collect the patient's procedure satisfaction score from 0 (worst satisfaction) to 10 (most satisfaction) at the conclusion of the procedure. Likewise, the blinded observer will also collect the final post-procedure heart rate and blood pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 13, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

2.2 years

First QC Date

January 12, 2024

Last Update Submit

February 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Critical-Care Pain Observation Tool (CPOT)

    To assess the differences in The Critical-Care Pain Observation Tool pain scores (as units) during lidocaine administration and at epidural Tuohy needle insertion between both groups. The Critical-Care Pain Observation Tool (CPOT) includes four behavioral pain indicators (facial expressions, body movements, muscle tension and patient's vocalizations) to assess pain in critical care settings, rating pain levels with a score from 0-8.

    Procedure (during lidocaine administration and at epidural Tuohy needle insertion)

Secondary Outcomes (4)

  • Numerical rating score (NRS) for pain

    Procedure (during lidocaine administration and at epidural Tuohy needle insertion)

  • Blood pressure (BP)

    at baseline, Procedure (during lidocaine administration and at epidural Tuohy needle insertion)

  • Heart Rate (HR)

    at baseline, Procedure (during lidocaine administration and at epidural Tuohy needle insertion)

  • Patient procedural satisfaction score

    at 30 minutes after the epidural procedure

Study Arms (2)

INTRADERMAL

ACTIVE COMPARATOR

Prior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine either intradermally (Group Intradermal).

Procedure: 1% Lidocaine Injection

SUBCUTANEOUS

ACTIVE COMPARATOR

Prior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine subcutaneously (Group Subcutaneous).

Procedure: 1% Lidocaine Injection

Interventions

Prior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine either intradermally (Group Intradermal) or subcutaneously (Group Subcutaneous).

INTRADERMALSUBCUTANEOUS

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParturient women requesting epidural analgesia for laboring pain at The Ohio State University Wexner Medical Center - Obstetric Anesthesia Division.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old
  • Parturient women requesting epidural analgesia for laboring pain
  • Ability to consent in English language

You may not qualify if:

  • Women undergoing cesarean delivery.
  • Administration of opioids in the 4 hours before study enrollment.
  • Administration of IV magnesium sulfate within the last 24 hours.
  • Diabetes mellitus (Type I and II).
  • Neurocardiogenic signs or symptoms (e.g., dizziness, lightheadedness, bradycardia, and syncope) during IV cannulation.
  • Cervical dilation \>6 cm (if in labor).
  • BMI ≥ 35.
  • Spinal anesthesia.
  • Chronic pain patients.
  • Opioid use disorder
  • Patient with intrauterine fetal demise
  • Prisoners.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Agnosia

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
A blinded observer (positioned in front of the patient and unable to see the procedure) will record data during the epidural procedure
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A single center, prospective, randomized, double blind pilot study for the evaluation of pain due to epidural Tuohy needle insertion with prior administration of subcutaneous or intradermal administration of lidocaine in parturient women requesting epidural analgesia for laboring pain at The Ohio State University Wexner Medical Center - Obstetric Anesthesia Division.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 12, 2024

First Posted

February 1, 2024

Study Start

November 13, 2023

Primary Completion

January 31, 2026

Study Completion

January 31, 2026

Last Updated

February 25, 2026

Record last verified: 2026-02

Locations